ResBiotic Pharma is harnessing the power of live biotherapeutics (LBPs) to develop breakthrough medicines specifically engineered to treat chronic lung disease.



ResMB Pipeline

Lung Health Starts Here

About RB1000

RB1000 is a pre-clinical phase LBP-based therapeutic for COPD.


About RB2000

RB2000 is a pre-clinical phase LBP-based therapy for Bronchopulmonary Dysplasia (BPD).


About RB3000

RB3000 is a pre-clinical phase LBP-based therapeutic for the treatment of Idiopathic Pulmonary Fibrosis and potentially other chronic lung diseases.


Join us in revolutionizing the standard of care

for chronic respiratory diseases.